← Eichor
Study identifier: NCT07394790 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effectiveness of a Physical Exercise Prescription Program in Primary Care for Adults Aged 65 and Older: PREFIS-AP

Condition: Sedentary Lifestyle  ·  Sponsor: Instituto de Investigación Biomédica de Salamanca

PhaseNA
Planned participants210
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersYes

About this study

This randomized controlled trial aims to evaluate the effectiveness of an individualized Physical Exercise Prescription Program delivered in Primary Care for adults aged 65 years and older. The intervention includes a structured assessment of physical fitness, muscle function and mass, physical activity level, and quality of life, followed by a tailored exercise plan encompassing aerobic, strength, respiratory, flexibility, and balance training. Outcomes will be compared with a control group receiving standard health advice to walk briskly for at least 30 minutes daily. The study also explores associations between polypharmacy, muscle function, physical performance, and quality of life.

This description comes directly from the study's public registry record.

Talk to the study team

Víctor Manuel González Rodríguez, MD  ·  +34923 356 677  ·  vmgonzalez@saludcastillayleon.es

Always discuss trial participation with your own doctor first.

Locations (1)

Centro de Salud de VilloriaVilloría, Salamanca, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07394790